Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Rawlins

Showing results (171-180 of 275) with videos related to

Pageof 28
Sort By:
The Quarterly Journal of Medicine|April 1, 1989
Extrapyramidal reactions to metoclopramide and prochlorperazineD N Bateman, W M Darling, R Boys, et al.
Clinical Science (London, England : 1979)|July 1, 1982
Propranolol absorption in untreated coeliac diseaseG I Sandle, A Ward, M D Rawlins, et al.
International Journal of Biometeorology|December 1, 1971
Noradrenergic mechanism in the central control of body temperatureW I Cranston, R F Hellon, R H Luff, et al.
British Journal of Pharmacology|November 1, 1972
Effects of chlorpromazine on thermoregulatory reflexes in manW I Cranston, T H Foley, R H Luff, et al.
British Medical Journal (Clinical Research Ed.)|January 3, 1981
Antipyrine clearance in psoriasisP H Chapman, B Keys, M D Rawlins, et al.
Thrombosis and Haemostasis|June 28, 1982
Predicting the dose of warfarin for therapeutic anticoagulationN K Sharma, P A Routledge, M D Rawlins, et al.
British Journal of Pharmacology|July 1, 1979
The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings]D N Bateman, D K Dutta, H A McClelland, et al.
European Journal of Clinical Pharmacology|June 12, 1979
Factors affecting warfarin requirements. A prospective population studyP A Routledge, P H Chapman, D M Davies, et al.
Human Toxicology|January 1, 1985
Opiate-induced rhabdomyolysisP G Blain, R J Lane, D N Bateman, et al.
British Journal of Clinical Pharmacology|August 1, 1994
Why the Safety Assessment of Marketed Medicines (SAMM) guidelines are neededP C Waller, S M Wood, A M Breckenridge, et al.
Pageof 28

Showing results (171-180 of 275) with videos related to

Sort By:
Pageof 28
The Quarterly Journal of Medicine|April 1, 1989
Extrapyramidal reactions to metoclopramide and prochlorperazineD N Bateman, W M Darling, R Boys, et al.
Clinical Science (London, England : 1979)|July 1, 1982
Propranolol absorption in untreated coeliac diseaseG I Sandle, A Ward, M D Rawlins, et al.
International Journal of Biometeorology|December 1, 1971
Noradrenergic mechanism in the central control of body temperatureW I Cranston, R F Hellon, R H Luff, et al.
British Journal of Pharmacology|November 1, 1972
Effects of chlorpromazine on thermoregulatory reflexes in manW I Cranston, T H Foley, R H Luff, et al.
British Medical Journal (Clinical Research Ed.)|January 3, 1981
Antipyrine clearance in psoriasisP H Chapman, B Keys, M D Rawlins, et al.
Thrombosis and Haemostasis|June 28, 1982
Predicting the dose of warfarin for therapeutic anticoagulationN K Sharma, P A Routledge, M D Rawlins, et al.
British Journal of Pharmacology|July 1, 1979
The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings]D N Bateman, D K Dutta, H A McClelland, et al.
European Journal of Clinical Pharmacology|June 12, 1979
Factors affecting warfarin requirements. A prospective population studyP A Routledge, P H Chapman, D M Davies, et al.
Human Toxicology|January 1, 1985
Opiate-induced rhabdomyolysisP G Blain, R J Lane, D N Bateman, et al.
British Journal of Clinical Pharmacology|August 1, 1994
Why the Safety Assessment of Marketed Medicines (SAMM) guidelines are neededP C Waller, S M Wood, A M Breckenridge, et al.
Pageof 28